Target intelligence / Profile preview

PMF1-BGLAP readthrough (PMF1-BGLAP)

Target
PMF1-BGLAP
Molecular classification
Other (readthrough transcript), Not classified as a receptor, enzyme, transporter, channel, or transcription factor
01

Overview

PMF1-BGLAP readthrough is a locus on chromosome 1 that represents naturally occurring readthrough transcription between the adjacent PMF1 and BGLAP genes. This event leads to transcript variants sharing sequence with the PMF1 protein at the N-terminus, but diverging at the C-terminus due to frameshifts, and the biological significance of the resulting protein(s), if any, remains unclear. There are multiple transcript variants, but no evidence for a distinct, therapeutically relevant protein product beyond the known functions of PMF1 (polyamine homeostasis, transcriptional regulation) and BGLAP (osteocalcin, bone metabolism)[1][3][5]. In summary: PMF1-BGLAP readthrough is not a canonical therapeutic target. The entry is likely not relevant for direct drug development, receptor targeting, or clinical biomarker applications. The main roles and disease associations are attributed to its parental genes, not the readthrough product. is_incorrect = true: because this entry conflates two different gene products and is not a conventional therapeutic target in itself. If you require information about the individual genes (PMF1 or BGLAP/osteocalcin), each is a distinct and biologically important entity with separate clinical and therapeutic relevance[2][5].

Other names
PMF-1PMF1PMF1-BGLAP proteinPolyamine-modulated factor 1PMF1-BGLAP
02

Mechanism of action

Not applicable (no drugs target this entity).

03

Biological functions

No well-defined biological function for the readthrough itself[1][3].Parental gene roles for context: PMF1: Transcriptional co-activator, involvement in polyamine metabolism, gene expression regulation[2][4].Parental gene roles for context: BGLAP (osteocalcin): Bone formation, metabolic regulation[5].
04

Disease associations

Phototoxic dermatitis (linked to parental gene PMF1)[3]Cerebral arteriopathy, autosomal dominant, with subcortical infarcts (linked to parental gene BGLAP)[3]No direct disease associations for the PMF1-BGLAP readthrough product itself.
05

Safety considerations

None described in the literature for the readthrough product.
06

Interacting drugs

None known for the readthrough transcript/protein.

1 more in the full profile.

07

Biomarkers

None known or validated.

Beyond the preview

Go deeper on PMF1-BGLAP readthrough (PMF1-BGLAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PMF1-BGLAP readthrough (PMF1-BGLAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call